UBS analyst Graham Doyle upgraded GE HealthCare (GEHC) to Neutral from Sell with a $73 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Johnson & Johnson Stock (JNJ) Perks Up as it Mulls $2.5B Purchase of Sonic Beam Cancer Fighting MedTech
- GE HealthCare announces intended expansion of radiation oncology portfolio
- GE HealthCare participates in a conference call with JPMorgan
- Strong Q1 Performance and Strategic Initiatives Drive Buy Rating for GE Healthcare Technologies Inc
- GE HealthCare price target lowered to $89 from $103 at Wells Fargo